A newly published AGA guideline for colorectal cancer (CRC) recommends all patients with a new diagnosis of CRC undergo testing for Lynch syndrome.
A regular regimen of aspirin can reduce additional cancer risk for obese individuals, according to study data.
Researchers have found an association between the risk of endometrial cancer and the age of first menstrual cycle, having given birth, and hormonal contraceptive use for women with Lynch syndrome.
Screening families of patients with colorectal cancer for a genetic condition would reduce their risk of developing related cancers, new research has determined.
Of the 143,000 patients with colorectal cancer diagnoses annually in the United States, up to 25% have a familial risk of colorectal cancer. A new guideline from the US Multi-Society Task Force on Colorectal Cancer recommends genetic testing of tumors for all newly diagnosed cases of colorectal cancer.
Scientific evidence is mounting that warrants screening all patients with endometrial cancer for Lynch syndrome.
Men with an inherited genetic condition called Lynch syndrome face a higher lifetime risk of developing prostate cancer and appear to develop the disease at an earlier age, according to a new study.
- Coping With Lymphedema: A Patient Guide (Fact Sheet)
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|